Harmonet

Harmonet is a combined oral contraceptive tablet containing the synthetic estrogen ethinylestradiol and the progestogen gestodene. It is marketed in the European Union as a prescription medication. Each tablet delivers a fixed dose of these hormones to provide reliable contraception. The product is taken orally and is classified under the ATC code G03AA09. The formulation follows standard dosing regimens used for cycle regulation and dysmenorrhea management.

Harmonet is prescribed for several hormonal indications related to reproductive health.

- Prevention of pregnancy as a combined oral contraceptive. - Regulation of the menstrual cycle, helping to achieve more predictable bleeding patterns. - Management of moderate to severe dysmenorrhea associated with ovulatory cycles. - Treatment of acne that is responsive to hormonal therapy. - Reduction of the risk of ovarian cyst formation in women with a history of functional cysts.

Like all hormonal contraceptives, Harmonet may cause a range of side effects; most are mild and resolve without treatment, but some require medical attention.

Common: - Nausea or mild stomach upset, often occurring during the first weeks of therapy. - Breast tenderness or slight enlargement, which usually diminishes after continued use. - Headache or migraine episodes, which may be relieved with over‑the‑counter analgesics. - Spotting, breakthrough bleeding, or irregular periods, especially during the initial cycles.

Serious: - Leg pain, swelling, or sudden shortness of breath that could indicate a blood clot (deep‑vein thrombosis or pulmonary embolism). - Severe hypertension or a rapid rise in blood pressure, which may present with headache, visual changes, or chest discomfort. - Liver problems such as jaundice, dark urine, or persistent abdominal pain, suggesting hepatic dysfunction.

Before starting Harmonet, certain health considerations should be reviewed to ensure safe use.

- Contraindicated in women who are pregnant, breastfeeding, or have known or suspected pregnancy. - Not recommended for individuals with a history of thromboembolic disorders, stroke, or myocardial infarction. - Caution in smokers aged 35 years or older due to increased cardiovascular risk. - Evaluate liver disease, as impaired hepatic function can affect hormone metabolism. - Review any history of hormone‑sensitive cancers, such as breast or endometrial cancer. - Consider potential worsening of migraine with aura.

Harmonet can interact with other medicines, which may alter its effectiveness or increase the risk of adverse events.

Avoid: - Strong enzyme inducers such as rifampicin, carbamazepine, phenytoin, or St John’s wort, which can reduce contraceptive efficacy. - Certain antiviral medications (e.g., some protease inhibitors) that may affect hormone levels.

Use with caution: - Antifungal agents like ketoconazole or itraconazole, which can increase hormone concentrations. - Selective serotonin reuptake inhibitors (SSRIs) that may heighten the risk of bleeding. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that can increase blood pressure.